Crop Life Science (NSE:CLSL) 5-Year EBITDA Growth Rate: 19.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CLSL Crop Life Science Ltd NSE:CLSL
75 GF Score
Price ₹80.00
GF Value ₹56.17
Valuation Significantly Overvalued
! 11 Warning Signs
View Full Analysis

What is Crop Life Science 5-Year EBITDA Growth Rate?

Crop Life Science NSE:CLSL -3.21% 75 5-Year EBITDA Growth Rate is 19.00% as of Mar. 2026. GuruFocus rates NSE:CLSL with a GF Score™ of 75/100 and a GF Value™ of ₹56.17 (Significantly Overvalued). The stock has 11 warning signs investors should review.

Crop Life Science's EBITDA per Share for the six months ended in Mar. 2026 was ₹4.39.

During the past 12 months, Crop Life Science's average EBITDA Per Share Growth Rate was 16.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 15.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Crop Life Science was 27.50% per year. The lowest was 14.00% per year. And the median was 17.30% per year.


Crop Life Science  (NSE:CLSL) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Crop Life Science 5-Year EBITDA Growth Rate Related Terms


NSE:CLSL vs CTVA, CF, MOS: 5-Year EBITDA Growth Rate Comparison

For the Agricultural Inputs subindustry, Crop Life Science's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Crop Life Science 5-Year EBITDA Growth Rate vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Crop Life Science's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Crop Life Science's 5-Year EBITDA Growth Rate falls into.


NSE:CLSL
75GF Score
Crop Life Science Ltd NSE:CLSL
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crop Life Science 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 19.00% mean?
Crop Life Science (NSE:CLSL) has a 5-Year EBITDA Growth Rate of 19.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Crop Life Science and its competitors.
Is Crop Life Science's 5-Year EBITDA Growth Rate too high?
Crop Life Science's current 5-Year EBITDA Growth Rate is 19.00%. Overall, Crop Life Science has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's 5-Year EBITDA Growth Rate compare to CTVA and CF?
Crop Life Science's 5-Year EBITDA Growth Rate of 19.00% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for an Agriculture company?
A good 5-Year EBITDA Growth Rate depends on the Agriculture industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Crop Life Science and its competitors. Crop Life Science's current 5-Year EBITDA Growth Rate is 19.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹56.17, compared to a current price of ₹80.00 — trading 42.4% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 19.00%. Crop Life Science's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current 5-Year EBITDA Growth Rate is 19.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crop Life Science (NSE:CLSL) Overvalued in 2026?

Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued. The current stock price of ₹80.00 is trading 42.4% above its estimated GF Value™ of ₹56.17. GuruFocus considers Crop Life Science to be Significantly Overvalued.

Key valuation signals for NSE:CLSL:

  • 5-Year EBITDA Growth Rate: 19.00%
  • GF Value™: ₹56.17 vs. price of ₹80.00 (42.4% above fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Crop Life Science Business Description

Address Old Padra Road, 6th Floor, ABS Tower, Near Chakli Circle, Vadodara, GJ, IND, 390007
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
75GF Score

Get the complete analysis for NSE:CLSL

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹80.00
Price
₹56.17
GF Value